Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergey O Sulima

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Oncotarget|November 23, 2017
Ribosomal proteins: a novel class of oncogenic driversSergey O Sulima, Kim De Keersmaecker
Cells|October 9, 2019
The Expanding RiboverseSergey O Sulima, Jonathan D Dinman
Hemasphere|March 20, 2019
Bloody Mysteries of RibosomesSergey O Sulima, Kim De Keersmaecker
Oncotarget|November 17, 2018
Rise of the specialized onco-ribosomesKim R Kampen, Sergey O Sulima, Kim De Keersmaecker
Blood|January 11, 2015
Ribosomopathies and the paradox of cellular hypo- to hyperproliferationKim De Keersmaecker, Sergey O Sulima, Jonathan D Dinman
Cells|March 14, 2019
Cancer Biogenesis in RibosomopathiesSergey O Sulima, Kim R Kampen, Kim De Keersmaecker
Nucleic Acids Research|July 28, 2019
Hallmarks of ribosomopathiesKim R Kampen, Sergey O Sulima, Stijn Vereecke, et al.
Cancer Discovery|September 20, 2017
How Ribosomes Translate CancerSergey O Sulima, Isabel J F Hofman, Kim De Keersmaecker, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesisSergey O Sulima, Stephanie Patchett, Vivek M Advani, et al.
Nucleic Acids Research|November 12, 2013
Eukaryotic rpL10 drives ribosomal rotationSergey O Sulima, Suna P Gülay, Margarida Anjos, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Oncotarget|November 23, 2017
Ribosomal proteins: a novel class of oncogenic driversSergey O Sulima, Kim De Keersmaecker
Cells|October 9, 2019
The Expanding RiboverseSergey O Sulima, Jonathan D Dinman
Hemasphere|March 20, 2019
Bloody Mysteries of RibosomesSergey O Sulima, Kim De Keersmaecker
Oncotarget|November 17, 2018
Rise of the specialized onco-ribosomesKim R Kampen, Sergey O Sulima, Kim De Keersmaecker
Blood|January 11, 2015
Ribosomopathies and the paradox of cellular hypo- to hyperproliferationKim De Keersmaecker, Sergey O Sulima, Jonathan D Dinman
Cells|March 14, 2019
Cancer Biogenesis in RibosomopathiesSergey O Sulima, Kim R Kampen, Kim De Keersmaecker
Nucleic Acids Research|July 28, 2019
Hallmarks of ribosomopathiesKim R Kampen, Sergey O Sulima, Stijn Vereecke, et al.
Cancer Discovery|September 20, 2017
How Ribosomes Translate CancerSergey O Sulima, Isabel J F Hofman, Kim De Keersmaecker, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesisSergey O Sulima, Stephanie Patchett, Vivek M Advani, et al.
Nucleic Acids Research|November 12, 2013
Eukaryotic rpL10 drives ribosomal rotationSergey O Sulima, Suna P Gülay, Margarida Anjos, et al.
Pageof 2